Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • Editorial Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Multiple Hereditary Exostoses

Back to Topics
Contents
0%

Multiple Hereditary Exostoses

Comprehensive guide to Multiple Hereditary Exostoses (HME/MHE) covering diagnosis, deformity, malignant transformation, and surgical management.

complete
Updated: 2026-01-02
High Yield Overview

Multiple Hereditary Exostoses

Osteochondromas Throughout the Skeleton

EXT1/EXT2 MutationGenetics
Autosomal DominantInheritance
1-5%Malignant Risk
KneeMost Common Site

Key Issues

Benign
PatternMost osteochondromas.
TreatmentObserve or excise if symptomatic
Malignant Transformation
Pattern1-5% become chondrosarcoma.
TreatmentWide excision
Deformity
PatternForearm, ankle.
TreatmentCorrective surgery

Critical Must-Knows

  • EXT1/EXT2: Tumor suppressor genes.
  • Malignant Transformation: 1-5% to chondrosarcoma.
  • Warning Signs: New growth, pain, size greater than 5cm in adults.
  • Forearm Deformity: Common (ulnar shortening).
  • Excision: For symptomatic lesions.

Examiner's Pearls

  • "
    EXT1/EXT2 mutations
  • "
    1-5% malignant transformation
  • "
    Pain/growth in adults = concerning
  • "
    Forearm deformity common

Malignant Transformation

Warning signs of malignant transformation to chondrosarcoma:

  • New pain in a previously painless lesion.
  • Growth after skeletal maturity.
  • Size greater than 5cm cartilage cap on imaging.
  • Irregular margins, scattered calcifications.
  • Obtain MRI. If concerning, biopsy or excise with wide margins.

MHE Features

IssueDetailsManagement
1-5% to chondrosarcomaWide excision if suspected
Ulnar shortening, radial bowingUlnar lengthening, osteotomy
Pain, nerve compressionExcision
Mnemonic

MHE Features

E
EXT1/EXT2
Gene mutations
M
Multiple
Osteochondromas
M
Malignant
1-5% risk

Memory Hook:EMM - EXT, Multiple, Malignant risk.

Mnemonic

Malignant Warning Signs

P
Pain
New pain in adults
G
Growth
After skeletal maturity
S
Size
greater than 5cm cap

Memory Hook:PGS - Pain, Growth, Size.

Mnemonic

Forearm Deformity in MHE

U
Ulnar shortening
Common site of osteochondroma
R
Radial bowing
Secondary deformity
D
Dislocation
Radial head may dislocate

Memory Hook:URD - Ulnar short, Radial bow, Dislocation risk.

Overview/Epidemiology

Multiple Hereditary Exostoses (MHE) is characterized by multiple osteochondromas.

  • Genetics: Autosomal dominant. EXT1 or EXT2 mutations (tumor suppressor genes).
  • Incidence: 1 in 50,000.
  • Pathophysiology: Loss of EXT function leads to abnormal cartilage growth at physes → osteochondromas.
  • EXT1 vs EXT2: EXT1 mutations (chromosome 8) typically cause more severe phenotype than EXT2 (chromosome 11).
  • Natural History: Lesions grow until skeletal maturity, then stop. Malignancy risk persists lifelong.

Pathophysiology and Mechanisms

Osteochondroma Structure

  • Cartilage-capped bony outgrowth arising from the metaphysis.
  • Continuous with host bone cortex and medulla.
  • Grows away from the adjacent joint (important for diagnosis).
  • Cartilage cap: Normally less than 1cm in adults, greater than 2cm concerning for malignancy.

Why Deformity Occurs

  • Osteochondromas at the distal ulna → ulnar shortening → radial bowing.
  • Tethering effect on growth plate.
  • Similar mechanism at ankle (fibular lesions) → ankle valgus.

Common Sites

  • Distal femur (most common).
  • Proximal tibia.
  • Proximal humerus.
  • Distal ulna/radius (causes forearm deformity).

Classification Systems

Masada Classification (Forearm Deformity)

  • Type I: Distal ulna osteochondroma → ulnar shortening.
  • Type IIA: As above + distal radial osteochondroma → radial articular surface tilt.
  • Type IIB: As above + subluxation/dislocation of radial head.
  • Type III: Proximal radioulnar involvement.

MHE Severity Classification

  • Mild: Few lesions, minimal deformity, no functional impairment.
  • Moderate: Multiple lesions, some deformity, mild functional issues.
  • Severe: Numerous lesions, significant deformity, major functional impairment, early surgery needed.

Clinical Assessment

History:

  • Age of first lesion.
  • Symptomatic lesions (pain, cosmesis, nerve compression).
  • Family history.
  • Any new pain or growth in adults (malignancy concern).

Physical Exam:

  1. Palpable Masses: Typically at metaphyses.
  2. Deformity: Forearm (short ulna), ankle (valgus).
  3. ROM: Limited by impingement.
  4. Neurovascular: Peroneal nerve at knee, etc.

Investigations

Imaging:

  • X-ray: Multiple osteochondromas, broad-based or pedunculated.
  • MRI: If malignancy suspected (cartilage cap thickness greater than 2cm or irregular).

Genetic:

  • EXT1/EXT2 testing if diagnosis uncertain.

Management Algorithm

Observation

  • Asymptomatic lesions: Watch and wait.
  • Regular clinical follow-up.
  • Educate on warning signs for malignancy.

Excision

  • Indications: Symptomatic (pain, nerve compression, cosmesis).
  • Technique: Marginal excision with cartilage cap. Avoid incomplete excision (recurrence).
  • If malignancy suspected: Wide excision.

Forearm Deformity

  • Ulnar Shortening: Causes radial bowing, radial head dislocation.
  • Surgery: Ulnar lengthening, radial osteotomy, osteochondroma excision.

Surgical Techniques

Osteochondroma Excision

Indications: Symptomatic lesions (pain, nerve compression, impingement).

Technique:

  • Marginal excision at the base.
  • Include entire cartilage cap to prevent recurrence.
  • Careful of adjacent neurovascular structures.

Pearl: Incomplete excision of cartilage cap leads to recurrence.

Forearm Deformity Correction

Indications: Progressive deformity, limited forearm rotation, radial head instability.

Procedures:

  • Osteochondroma excision (distal ulna/radius).
  • Ulnar lengthening (gradual or acute).
  • Radial osteotomy for bowing.
  • Radial head reduction if dislocated.

Timing: Early intervention prevents radial head dislocation.

Chondrosarcoma Excision

Indications: Confirmed or suspected malignant transformation.

Technique:

  • Wide excision margins.
  • Limb salvage if possible.
  • Oncology involvement.

Note: Chondrosarcoma is chemotherapy/radiation resistant.

Complications

ComplicationContextManagement
Malignant Transformation1-5%, lifelong riskSurveillance, wide excision
RecurrenceIncomplete excisionComplete cartilage cap removal
Nerve InjuryPeroneal at kneeCareful dissection
Deformity ProgressionChildhood growthEarly intervention
Vascular InjuryPopliteal regionPre-op imaging

Postoperative Care

  • Simple Excision: Early mobilization, wound care.
  • Forearm Reconstruction: Splinting, protected ROM.
  • Lengthening: Fixator care, daily adjustments.
  • All Patients: Continue surveillance for other lesions.

Outcomes/Prognosis

  • Most lesions remain benign.
  • Malignant transformation: 1-5%.
  • Significant deformity may limit function.

Evidence Base

Review
📚 Bovée et al
Key Findings:
  • EXT genes and pathogenesis
  • Malignant transformation risk
  • Surveillance guidelines
Clinical Implication: Know the malignant transformation rate.
Source: Lancet Oncol 2010

Review
📚 Stieber and Dormans
Key Findings:
  • MHE management overview
  • Forearm deformity treatment
  • Excision for symptoms
Clinical Implication: Comprehensive management.
Source: J Am Acad Orthop Surg 2005

Level IV
📚 Masada et al
Key Findings:
  • Classification of forearm deformity
  • Types I, IIA, IIB, III defined
  • Treatment recommendations by type
Clinical Implication: Use Masada classification for forearm deformity.
Source: J Pediatr Orthop 1989

Level IV
📚 Schmale et al
Key Findings:
  • Natural history of MHE
  • 1-5% malignant transformation rate
  • Long-term outcomes
Clinical Implication: Lifelong surveillance for malignancy.
Source: J Bone Joint Surg Am 1994

Level IV
📚 Porter et al
Key Findings:
  • MHE clinical burden
  • Quality of life impact
  • Functional outcomes
Clinical Implication: Consider functional impact beyond deformity.
Source: J Bone Joint Surg Br 2004

Viva Scenarios

Practice these scenarios to excel in your viva examination

VIVA SCENARIOStandard

New Pain in an Osteochondroma

EXAMINER

"30-year-old with known MHE. One of his knee lesions has become painful and appears to have grown over the past year."

EXCEPTIONAL ANSWER

This is **concerning for malignant transformation**. In an adult with known MHE, new pain and growth are red flags. I would order an **MRI** to assess the cartilage cap thickness (greater than 2cm is concerning) and look for irregular margins. If suspicious, I would perform **wide excision** rather than marginal. Histology is essential. If chondrosarcoma is confirmed, further oncological management is needed.

KEY POINTS TO SCORE
Pain + growth in adult = concerning
MRI to assess
Wide excision if suspicious
COMMON TRAPS
✗Ignoring the symptoms
✗Marginal excision of a malignancy
LIKELY FOLLOW-UPS
"What is the malignant transformation rate?"
VIVA SCENARIOStandard

Forearm Deformity

EXAMINER

"10-year-old with MHE has progressive forearm deformity with limited pronation/supination."

EXCEPTIONAL ANSWER

Forearm deformity is common in MHE due to osteochondromas affecting the distal ulna, causing **ulnar shortening and radial bowing**. Management: **Excise symptomatic osteochondromas**. If significant deformity, consider **ulnar lengthening** and **radial osteotomy** to restore alignment and forearm rotation. Early intervention may prevent radial head dislocation.

KEY POINTS TO SCORE
Ulnar shortening causes deformity
Excise osteochondromas
Lengthening/osteotomy if needed
COMMON TRAPS
✗Ignoring progressive deformity
LIKELY FOLLOW-UPS
"What genes are mutated?"
VIVA SCENARIOStandard

Nerve Compression

EXAMINER

"12-year-old with MHE presents with foot drop. X-ray shows large osteochondroma at proximal fibula. How do you manage?"

EXCEPTIONAL ANSWER

This is a **peroneal nerve compression** from an osteochondroma at the fibular head. This is a common site for nerve compression in MHE. Management: I would obtain an **MRI** to assess the lesion and relationship to the nerve. Given the neurological deficit, this is an indication for **surgical excision**. I would excise the osteochondroma with careful dissection around the peroneal nerve. Post-op, I would monitor for nerve recovery and consider AFO for foot drop.

KEY POINTS TO SCORE
Peroneal nerve at fibular head
Neurological deficit = surgical indication
Careful dissection
COMMON TRAPS
✗Not recognizing the cause
✗Damaging nerve during excision
LIKELY FOLLOW-UPS
"What other nerves can be compressed?"

MCQ Practice Points

Genetics MCQ

Q: What genes are mutated in MHE? A: EXT1 and EXT2.

Malignancy MCQ

Q: What is the malignant transformation rate? A: 1-5% to chondrosarcoma.

Warning MCQ

Q: What are warning signs for malignancy? A: Pain, growth after skeletal maturity, cartilage cap greater than 2cm.

Forearm Pearl

Q: What causes forearm deformity in MHE? A: Distal ulnar osteochondroma causes ulnar shortening, leading to radial bowing and potential radial head dislocation.

Classification Pearl

Q: What is the Masada classification used for? A: Forearm deformity in MHE. Types I-III based on ulnar shortening, radial deformity, and radial head status.

Nerve Pearl

Q: Which nerve is commonly compressed at the knee in MHE? A: Common peroneal nerve (fibular head osteochondroma).

Australian Context

  • Genetic Testing: EXT1/EXT2 available through clinical genetics.
  • Multidisciplinary Care: Orthopaedics, genetics, oncology.
  • Support Groups: MHE Australia (patient support).
  • Surveillance: Regular clinical review, educate on warning signs.
  • PBS: No specific medications; surgical management covered.

MULTIPLE HEREDITARY EXOSTOSES

High-Yield Exam Summary

GENETICS

  • •EXT1/EXT2
  • •Autosomal Dominant
  • •Tumor suppressors
  • •1 in 50,000

CLINICAL

  • •Multiple osteochondromas
  • •Metaphyses
  • •Forearm deformity
  • •Knee most common

MALIGNANCY

  • •1-5% transformation
  • •Pain in adults
  • •Growth after maturity
  • •Cap greater than 2cm

TREATMENT

  • •Observe if asymptomatic
  • •Excise if symptomatic
  • •Wide excision if malignant
  • •Correct deformity

FOREARM

  • •Ulnar shortening
  • •Radial bowing
  • •Masada classification
  • •Early intervention prevents RH dislocation

NERVES

  • •Peroneal at fibular head
  • •Sciatic at hip
  • •Foot drop = excision
  • •Pre-op imaging

Self-Assessment Quiz

Differential Diagnosis

Multiple Cartilaginous Lesions:

ConditionKey FeaturesDifferentiator
MHEMultiple osteochondromasContinuous cortex, metaphyses, EXT mutation
Ollier DiseaseMultiple enchondromasMedullary lesions, not cortical
Maffucci SyndromeEnchondromas + hemangiomasSoft tissue vascular lesions
MetachondromatosisOsteochondromas + enchondromasBoth lesion types present
Dysplasia Epiphysealis HemimelicaEpiphyseal osteochondromaSingle limb, epiphysis involved

Key Distinguishing Points:

  • MHE: Metaphyseal, cortex continuous with host bone.
  • Enchondromas (Ollier): Medullary, radiolucent with stippled calcifications.
  • DEH (Trevor Disease): Single limb, epiphyseal involvement.
  • Malignancy risk: MHE 1-5%, Ollier 25-30%, Maffucci 25-30%.

Additional Quiz Questions

Quick Stats
Reading Time45 min
Related Topics

Accessory Navicular

Achondroplasia

Arthrogryposis

Charcot-Marie-Tooth Disease